Thanks for sharing!
i noticed that you dropped the price per dose to $1,500 when you increased the market size. Is there any info on pricing margins that insurance companies use/accept? I read recently that ozempic has done $50B in revenue this year and that there are calls to reprice the drug because initially the pricing was based on it being used for T2D only and a much smaller market than what it is currently being used for.
@RaceOncology Perhaps you have insights into pricing margins that the Triangle report looked at which resulted in a dose price of $15,000?
Thanks for sharing! i noticed that you dropped the price per...
-
- There are more pages in this discussion • 23 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.53 |
Change
-0.060(3.79%) |
Mkt cap ! $259.9M | |||
| Open | High | Low | Value | Volume |
| $1.54 | $1.56 | $1.53 | $130.2K | 84.73K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 4993 | $1.53 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.58 | 10451 | 1 |
View Market Depth
| Last trade - 16.10pm 18/10/2024 (20 minute delay) ? |
| RAC (ASX) Chart |